Cappato IST
2012
Clinical Efficacy of Ivabradine in Patients with Inappropriate Sinus Tachycardia
In 21 patients with symptomatic inappropriate sinus tachycardia, ivabradine eliminated most symptoms and lowered heart rate at rest, on standing and during exertion compared with placebo.
Result
Efficacy: Elimination of symptoms attributable to inappropriate sinus tachycardiarelative risk 0.25 (95% CI 0.18-0.34) · P < 0.001
Below 1 favours ivabradine, above 1 favours placebo.
Also reported: With complete elimination in 47 %. Resting heart rate fell from 88 to 76 bpm (p=0.011).
- Subtopic
- Inappropriate sinus tachycardia
- Design
- Double-blind, placebo-controlled crossover RCT
- Relevance
- Supporting: context rather than must-know.
- Cited in
- ESC 2019 SVTACC/AHA 2015 SVT
- Source
- Cappato R, Castelvecchio S, Ricci C, et al. J Am Coll Cardiol. 2012;60(15):1323-1329.doi 10.1016/j.jacc.2012.06.031
Discussion & critique
Very small, single-centre and short, with a subjective primary endpoint and no beta-blocker comparator: a proof of concept rather than a definitive trial. It is nevertheless the only randomised placebo-controlled evidence in inappropriate sinus tachycardia and is the entire basis of the ivabradine recommendation.